Elekta AB ADR
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $6.675
- Today's High:
- $6.71
- Open Price:
- $6.675
- 52W Low:
- $4.7658
- 52W High:
- $8.65
- Prev. Close:
- $6.62
- Volume:
- 14762
Company Statistics
- Market Cap.:
- $2.88 billion
- Book Value:
- 2.054
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $6.42 billion
- Profit Margin:
- 5.59%
- Return on Assets TTM:
- 4.44%
- Return on Equity TTM:
- 10.12%
Company Profile
Elekta AB ADR had its IPO on under the ticker symbol EKTAY.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Elekta AB ADR has a staff strength of 4,700 employees.
Stock update
Shares of Elekta AB ADR opened at $6.68 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $6.68 - $6.71, and closed at $6.71.
This is a +1.28% increase from the previous day's closing price.
A total volume of 14,762 shares were traded at the close of the day’s session.
In the last one week, shares of Elekta AB ADR have slipped by -5.56%.
Elekta AB ADR's Key Ratios
Elekta AB ADR has a market cap of $2.88 billion, indicating a price to book ratio of 2.7312 and a price to sales ratio of 1.6349.
In the last 12-months Elekta AB ADR’s revenue was $0 with a gross profit of $6.42 billion and an EBITDA of $0. The EBITDA ratio measures Elekta AB ADR's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Elekta AB ADR’s operating margin was 0% while its return on assets stood at 4.44% with a return of equity of 10.12%.
In Q0.33333333333333, Elekta AB ADR’s quarterly earnings growth was a positive 31.2% while revenue growth was a positive 20.9%.
Elekta AB ADR’s PE and PEG Ratio
- Forward PE
- 17.9856
- Trailing PE
- 37.7
- PEG
- 0.9115
Its diluted EPS in the last 12-months stands at $0.2 per share while it has a forward price to earnings multiple of 17.9856 and a PEG multiple of 0.9115. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Elekta AB ADR’s profitability.
Elekta AB ADR stock is trading at a EV to sales ratio of 0.1844 and a EV to EBITDA ratio of 1.0795. Its price to sales ratio in the trailing 12-months stood at 1.6349.
Elekta AB ADR stock pays annual dividends of $0 per share, indicating a yield of 3.02% and a payout ratio of 95.34%.
Balance sheet and cash flow metrics
- Total Assets
- $27.97 billion
- Total Liabilities
- $12.68 billion
- Operating Cash Flow
- $0
- Capital Expenditure
- $389 million
- Dividend Payout Ratio
- 95.34%
Elekta AB ADR ended 2024 with $27.97 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $27.97 billion while shareholder equity stood at $9.63 billion.
Elekta AB ADR ended 2024 with $0 in deferred long-term liabilities, $12.68 billion in other current liabilities, in common stock, $0 in retained earnings and $0 in goodwill. Its cash balance stood at $1.22 billion and cash and short-term investments were $1.22 billion. The company’s total short-term debt was $758,000,000 while long-term debt stood at $4.15 billion.
Elekta AB ADR’s total current assets stands at $13.25 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $4.24 billion compared to accounts payable of $1.39 billion and inventory worth $3.34 billion.
In 2024, Elekta AB ADR's operating cash flow was $0 while its capital expenditure stood at $389 million.
Comparatively, Elekta AB ADR paid $0.95 in dividends in 2024.
Other key metrics
- Current Trading Price
- $6.71
- 52-Week High
- $8.65
- 52-Week Low
- $4.7658
- Analyst Target Price
- $
Elekta AB ADR stock is currently trading at $6.71 per share. It touched a 52-week high of $8.65 and a 52-week low of $8.65. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $7.45 and 200-day moving average was $7.25 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0.3% are held by institutions.
Frequently Asked Questions About Elekta AB ADR
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.